SMT201700602T1 - Processo per la preparazione di derivati dell’acido biliare - Google Patents

Processo per la preparazione di derivati dell’acido biliare

Info

Publication number
SMT201700602T1
SMT201700602T1 SM20170602T SMT201700602T SMT201700602T1 SM T201700602 T1 SMT201700602 T1 SM T201700602T1 SM 20170602 T SM20170602 T SM 20170602T SM T201700602 T SMT201700602 T SM T201700602T SM T201700602 T1 SMT201700602 T1 SM T201700602T1
Authority
SM
San Marino
Prior art keywords
acid derivatives
bile acid
preparing bile
preparing
derivatives
Prior art date
Application number
SM20170602T
Other languages
English (en)
Italian (it)
Inventor
Roberto Pellicciari
Antimo Gioiello
Original Assignee
Intercept Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercept Pharmaceuticals Inc filed Critical Intercept Pharmaceuticals Inc
Publication of SMT201700602T1 publication Critical patent/SMT201700602T1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM20170602T 2012-10-26 2013-10-25 Processo per la preparazione di derivati dell’acido biliare SMT201700602T1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261718966P 2012-10-26 2012-10-26
PCT/US2013/066917 WO2014066819A1 (en) 2012-10-26 2013-10-25 Process for preparing bile acid derivatives
EP13849263.2A EP2912013B1 (en) 2012-10-26 2013-10-25 Process for preparing bile acid derivatives

Publications (1)

Publication Number Publication Date
SMT201700602T1 true SMT201700602T1 (it) 2018-03-08

Family

ID=50545344

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20170602T SMT201700602T1 (it) 2012-10-26 2013-10-25 Processo per la preparazione di derivati dell’acido biliare

Country Status (22)

Country Link
US (2) US9777038B2 (cg-RX-API-DMAC7.html)
EP (1) EP2912013B1 (cg-RX-API-DMAC7.html)
JP (1) JP6272888B2 (cg-RX-API-DMAC7.html)
KR (1) KR102068381B1 (cg-RX-API-DMAC7.html)
CN (2) CN105102425B (cg-RX-API-DMAC7.html)
AU (1) AU2013334122B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015009395A2 (cg-RX-API-DMAC7.html)
CA (1) CA2889592A1 (cg-RX-API-DMAC7.html)
CY (1) CY1119731T1 (cg-RX-API-DMAC7.html)
DK (1) DK2912013T3 (cg-RX-API-DMAC7.html)
ES (1) ES2655034T3 (cg-RX-API-DMAC7.html)
HK (1) HK1253301A1 (cg-RX-API-DMAC7.html)
HU (1) HUE036887T2 (cg-RX-API-DMAC7.html)
IL (1) IL238454B (cg-RX-API-DMAC7.html)
MX (1) MX361653B (cg-RX-API-DMAC7.html)
NO (1) NO2968302T3 (cg-RX-API-DMAC7.html)
NZ (2) NZ745013A (cg-RX-API-DMAC7.html)
PL (1) PL2912013T3 (cg-RX-API-DMAC7.html)
PT (1) PT2912013T (cg-RX-API-DMAC7.html)
SG (1) SG11201503247UA (cg-RX-API-DMAC7.html)
SM (1) SMT201700602T1 (cg-RX-API-DMAC7.html)
WO (1) WO2014066819A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9777038B2 (en) 2012-10-26 2017-10-03 Intercept Pharmaceuticals, Inc. Process for preparing bile acid derivatives
ES2938874T3 (es) 2014-05-29 2023-04-17 Bar Pharmaceuticals S R L Derivados de colano para su uso en el tratamiento y/o prevención de enfermedades mediadas por FXR y TGR5/GPBAR1
US20170327531A1 (en) 2014-11-19 2017-11-16 NZP UK Limited 6.alpha.-alkyl-6,7-dione steroids as intermediates for the production of steroidal fxr modulators
CN107207559B (zh) 2014-11-19 2019-10-25 Nzp英国有限公司 作为制备类固醇fxr调节剂的中间体的6-烷基-7-羟基-4-烯-3-酮类固醇
JP6724004B2 (ja) 2014-11-19 2020-07-15 エヌゼットピー ユーケー リミテッド ステロイドFXRモジュレーター製造のための中間体としての5β−6−アルキル−7−ヒドロキシ−3−オンステロイド
CN107108688B (zh) 2014-11-19 2019-10-29 Nzp英国有限公司 作为制备类固醇FXR调节剂的中间体的6α-烷基-3,7-二酮类固醇
CN104672290B (zh) * 2015-01-05 2017-06-06 北京普禄德医药科技有限公司 一种用于预防或治疗fxr‑介导的疾病的药物及其制备方法和用途
TN2017000344A1 (en) 2015-02-06 2019-01-16 Intercept Pharmaceuticals Inc Pharmaceutical compositions for combination therapy
CN108350020A (zh) * 2015-09-24 2018-07-31 英特塞普特医药品公司 用于制备胆汁酸衍生物的方法和中间体
BR112018008936A2 (pt) * 2015-11-06 2018-11-27 Intercept Pharmaceuticals Inc métodos para a preparação de ácido obeticólico e derivados do mesmo
US20200262865A1 (en) * 2016-02-15 2020-08-20 Alexander Khoruts Compositions and methods for treating clostridium associated diseases
KR102377338B1 (ko) 2016-04-13 2022-03-21 인터셉트 파마슈티컬즈, 인크. 암의 치료 방법
TW201738254A (zh) * 2016-04-19 2017-11-01 英特賽普醫藥品公司 奧貝膽酸及其衍生物之製備方法
GB201608776D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
GB201608777D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Compounds
CN109963567A (zh) * 2016-09-30 2019-07-02 英特塞普特医药品公司 胆汁酸衍生物的结晶形式
CA3070837A1 (en) 2017-07-24 2019-01-31 Intercept Pharmaceuticals, Inc. Isotopically labeled bile acid derivatives
JP7308811B2 (ja) * 2017-07-26 2023-07-14 チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド ステロイド系誘導体fxrアゴニストの製造方法
GB201812382D0 (en) 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds
AU2020284135A1 (en) 2019-05-30 2022-01-06 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions comprising a FXR agonist and a fibrate for use in the treatment of cholestatic liver disease
IL291985A (en) 2019-10-07 2022-06-01 Kallyope Inc Gpr119 agonists
PH12022552277A1 (en) 2020-02-28 2024-03-04 Kallyope Inc Gpr40 agonists
UY39222A (es) 2020-05-19 2021-11-30 Kallyope Inc Activadores de la ampk
EP4172162A4 (en) 2020-06-26 2024-08-07 Kallyope, Inc. AMPK ACTIVATORS
EP4215540A4 (en) 2020-09-18 2025-01-15 Seoul National University R & DB Foundation METHOD FOR MASS PRODUCTION OF SODIUM TAURODEOXYCHOLATE

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216015A (en) 1991-02-05 1993-06-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having hypocholesterolemic properties
DE60205891T2 (de) 2001-03-12 2006-06-22 Intercept Pharmaceuticals, Inc. Steroide als agonisten für fxr
EP1568706A1 (en) 2004-02-26 2005-08-31 Intercept Pharmaceuticals, Inc. Novel steroid agonist for FXR
EP2040713B1 (en) * 2006-06-27 2014-06-18 Intercept Pharmaceuticals Inc. Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions
WO2010036427A1 (en) * 2008-06-17 2010-04-01 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
AU2009276507B2 (en) * 2008-07-30 2015-11-19 Intercept Pharmaceuticals, Inc. TGR5 modulators and methods of use thereof
EP3150620B1 (en) * 2008-11-19 2020-01-08 Intercept Pharmaceuticals, Inc. Tgr5 modulators and methods of use thereof
US9777038B2 (en) 2012-10-26 2017-10-03 Intercept Pharmaceuticals, Inc. Process for preparing bile acid derivatives

Also Published As

Publication number Publication date
JP6272888B2 (ja) 2018-01-31
KR102068381B1 (ko) 2020-01-20
AU2013334122B2 (en) 2017-11-02
PL2912013T3 (pl) 2018-05-30
CA2889592A1 (en) 2014-05-01
JP2015533852A (ja) 2015-11-26
NZ745013A (en) 2019-08-30
BR112015009395A2 (pt) 2017-07-04
CN108250264A (zh) 2018-07-06
CN105102425B (zh) 2018-04-10
MX361653B (es) 2018-12-13
ES2655034T3 (es) 2018-02-16
SG11201503247UA (en) 2015-06-29
CY1119731T1 (el) 2018-06-27
US9777038B2 (en) 2017-10-03
IL238454B (en) 2018-11-29
PT2912013T (pt) 2018-01-03
NZ707389A (en) 2018-08-31
WO2014066819A1 (en) 2014-05-01
KR20150074062A (ko) 2015-07-01
EP2912013A4 (en) 2016-06-01
AU2013334122A1 (en) 2015-05-14
NO2968302T3 (cg-RX-API-DMAC7.html) 2018-02-03
EP2912013A1 (en) 2015-09-02
HK1214239A1 (zh) 2016-07-22
HUE036887T2 (hu) 2018-08-28
HK1253301A1 (zh) 2019-06-14
EP2912013B1 (en) 2017-10-11
DK2912013T3 (en) 2018-01-15
US20180079776A1 (en) 2018-03-22
MX2015005286A (es) 2015-10-29
US10202414B2 (en) 2019-02-12
US20150291653A1 (en) 2015-10-15
CN105102425A (zh) 2015-11-25
IL238454A0 (en) 2015-06-30

Similar Documents

Publication Publication Date Title
IL238454A0 (en) A process for the preparation of bile acid derivatives
HRP20181696T1 (hr) Postupak za pripremu dipeptidnih derivata lizin-glutaminske kiseline
SG11201503291RA (en) Process for producing acetic acid
IL232139A (en) A process for making quinoline history
IL238314A (en) Process for the preparation of an important compound of linagliptin
GB2506695B (en) Process for preparing an inhibited starch
SG11201404601QA (en) Acetic acid production method
IL222290A0 (en) Process for preparing aminobenzofuran derivatives
IL222191A0 (en) Process for preparing sulfonamido-benzofuran derivatives
SG11201504643WA (en) Integrated process for making acetic acid
IL227872A0 (en) A process for the preparation of n-converted phenylhydroxylamines
IL235802A0 (en) A new process for the preparation of 2-cyclopentyl-6-methoxy-isonicotinic acid
IL233945A0 (en) A method for the production of modified anthranilic acid precursors
IL227220A (en) A process for preparing a history of 3-alkylsulfinylbenzoyl
SG11201403205SA (en) Process for making levulinic acid
IL235630A (en) Process for making amino acid compounds
TWI562986B (en) Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compounds
PT2931696T (pt) Processo contínuo para a preparação de ácido (s)-2-acetiloxipropiónico
EP2619174A4 (en) PROCESS FOR THE PREPARATION OF L-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVES
IL239136A0 (en) A method for the production of derivatives of 3-mercapto-4-haloalkyl substituted 2-hydroxy-benzoic acid
ZA201405237B (en) Process for preparing formic acid
IL235300A0 (en) A process for the preparation of naphthyridine hist
GB201223319D0 (en) Process for producing lactic acid
IL238934A (en) Methods for making phenyloxymethyl-nitro-imidazole derivatives
HUP1200614A2 (en) Process for development catalayzer